-The Times of India Internationally acclaimed academician Noam Chomsky of Massachusetts Institute of Technology of the United States has warned that Koodankulam could be another Bhopal disaster in waiting. In a solidarity letter to the struggling people he said: "Nuclear energy is a very dangerous initiative, particularly in countries like India, which has had more than its share of industrial disasters, Bhopal being the most famous." "I would like to express my...

-WeeklyBlitz.net As India is approaching towards a general election in less than a year, the leader of ruling Indian National Congress has been listed as world's fourth richest politician with a total wealth of over US$ 18 billion, which is invested in real estate, telecommunication and various business projects around the world, while significant portion of the amount is also deposited in secret bank accounts. Italian born Indian politician Sonia Gandhi...

-The Indian Express The International Monetary Fund’s recent downgrading of the growth forecast for India from 6.2 per cent to 4.9 per cent for 2012, which came on the heels of the decline in the actual growth rate to below 5.5 per cent in the first half of 2012, has brought reforms back to the centrestage of the policy discourse. Which reforms are needed and why? India’s growth trajectory has been unique....

-The Indian Express Recently, the prime minister raised concerns about RTI applications encroaching on the right to privacy. At this juncture, it may be worth remembering the case of “Auto Shankar” and his diary. About 20 years ago, an auto driver called Gauri Shankar, who had murdered more than six teenage girls, was convicted and sentenced to death. Before the appeals process was exhausted, he started writing a diary, which was...

-The Times of India Medicines in India may not be sold under brand names in the near future. In its biggest move to push generic drugs and do away with brand names, the Union health ministry has ordered states to stop issuing licence for the manufacture or sale of drugs on the basis of their brand name. All pharmaceutical firms applying for licence to market or manufacture fixed dose combination (FDC) drugs will...